Fortune May 25, 2023
Giacomo Chiesi

Rare diseases have gained more attention in recent years, perhaps in part due to the high price tags often associated with approved therapies. But the cost of rare disease drugs is dwarfed by the cost of not having them.

Our recent study shows that a lack of treatment for a rare disease is associated with a 21.2% increase in total costs per patient per year. That places a significant burden on the healthcare system. While rare diseases impact a small population, the cost to society is staggering–we estimate that the societal cost in the U.S. for all 7,000 known rare diseases may be in the range of $7.2-$8.6 trillion per year.

Historically, there has been a lack of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Healthcare System, Patient / Consumer, Pharma, Pharma / Biotech, Pricing / Spending, Provider, Survey / Study, Trends
Explainer: US Election 2024 -Biden’s healthcare outlook
Amid proposed health insurance rate hikes, Vermont businesses say health costs are slowing growth
Hospital Price Transparency: Is the Juice worth the Squeeze?
Health insurers are ignoring price transparency rules at the expense of private practice
How Does Medical Inflation Compare to Inflation in the Rest of the Economy? - 2

Share This Article